Wilson Sonsini advised ImmunityBio, and Goodwin advised the placement agent.ImmunityBio, Inc. (NASDAQ: IBRX) announced that it has executed financing to provide further working capital and support its…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
